[Inhibition of enkephalins degradation in the nucleus accumbens leads to potentiation of acupuncture and morphine analgesia].
D015670:Acupuncture Therapy; D000626:Aminopeptidases / Q000037:antagonists & inhibitors; D000698:Analgesia; D000818:Animals; D004599:Electric Stimulation Therapy; D010450:Endopeptidases; D004743:Enkephalin, Leucine / Q000378:metabolism; D004744:Enkephalin, Methionine / Q000378:metabolism*; D007930:Leucine / Q000031:analogs & derivatives / Q000494:pharmacology; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D015260:Neprilysin; D009714:Nucleus Accumbens / Q000502:physiology*; D011480:Protease Inhibitors; D011817:Rabbits; D012686:Septal Nuclei / Q000502:physiology*; D015244:Thiorphan; D008625:Tiopronin / Q000031:analogs & derivatives / Q000494:pharmacology; D004561:Transcutaneous Electric Nerve Stimulation
D011480:Protease Inhibitors; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; D009020:Morphine; D015244:Thiorphan; D008625:Tiopronin; D010450:Endopeptidases; D000626:Aminopeptidases; D015260:Neprilysin; D007930:Leucine; C012211:ubenimex